Interestingly, COPD adenocarcinoma patients who had lower levels of AIM2 in the tumor tissue had higher survival rate (6.3 years) compared to patients who had higher levels of AIM2 in the tumor tissue (2.7 years) (Figure 6F, red vs black line). Here, AIM2 is linked to neoplasm.